Tesamorelin Pen

Tesamorelin is a synthetic analogue of Growth Hormone-Releasing Hormone (GHRH), structurally modified to enhance stability and biological activity. It is one of the most clinically validated peptides available, with an extensive research history and recognised applications in metabolic health and body composition.

What Tesamorelin is studied for:

• Visceral fat reduction - Tesamorelin has been studied in multiple clinical settings for its role in reducing visceral adipose tissue - the metabolically active fat stored around internal organs. It is one of the most researched peptides for this specific outcome

• Growth hormone stimulation - Works by stimulating the pituitary gland's natural production of growth hormone through the GHRH pathway, supporting the body's own hormonal processes rather than introducing exogenous hormones

• Metabolic and cardiovascular health - Research explores its influence on triglyceride levels, insulin sensitivity, and metabolic markers associated with cardiovascular health

• Body composition - Studied for its role in improving lean-to-fat mass ratios, particularly in the context of age-related metabolic changes

Tesamorelin represents one of the most rigorously researched growth hormone secretagogues available, with a body of clinical evidence distinguishing it from less-studied alternatives.